Explore

Trendline Trendline
Quantum-Si Reports Q1 2026 Financial Results and Advances Proteus Development

Quantum-Si Reports Q1 2026 Financial Results and Advances Proteus Development

Quantum-Si Reports Q1 2026 Financial Results and Advances Proteus Development
Trendline Trendline
Stevanato Group Reports 7% Revenue Growth in Q1 2026, Maintains Fiscal Guidance

Stevanato Group Reports 7% Revenue Growth in Q1 2026, Maintains Fiscal Guidance

Stevanato Group Reports 7% Revenue Growth in Q1 2026, Maintains Fiscal Guidance
Trendline Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Trendline Trendline
Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments

Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments

Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments
Trendline Trendline
BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position

BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position

BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position
Trendline Trendline
Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline
Trendline Trendline
Maravai LifeSciences Reports Significant Revenue Growth in Q1 2026 Amid Strong Demand

Maravai LifeSciences Reports Significant Revenue Growth in Q1 2026 Amid Strong Demand

Maravai LifeSciences Reports Significant Revenue Growth in Q1 2026 Amid Strong Demand
Trendline Trendline
Aurinia Pharmaceuticals Reports Strong Q1 2026 Financial Results and Reaffirms Revenue Guidance

Aurinia Pharmaceuticals Reports Strong Q1 2026 Financial Results and Reaffirms Revenue Guidance

Aurinia Pharmaceuticals Reports Strong Q1 2026 Financial Results and Reaffirms Revenue Guidance
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Trendline Trendline
Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth

Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth

Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Trendline Trendline
Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast